NYSE:PRA - ProAssurance Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$37.45 -0.40 (-1.06 %)
(As of 07/18/2018 02:43 AM ET)
Previous Close$37.85
Today's Range$37.35 - $38.25
52-Week Range$34.95 - $63.45
Volume382,700 shs
Average Volume336,689 shs
Market Capitalization$1.95 billion
P/E Ratio18.74
Dividend Yield3.41%
ProAssurance logoProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation, and Lloyd's Syndicate segments. It offers professional liability insurance for healthcare professionals and facilities; professional liability insurance for attorneys; liability insurance for medical technology and life sciences risks; and workers' compensation insurance for employers, groups, and associations. The company markets its products through independent agencies and brokers, as well as an internal sales force. ProAssurance Corporation was founded in 1976 and is headquartered in Birmingham, Alabama.

Receive PRA News and Ratings via Email

Sign-up to receive the latest news and ratings for PRA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Fire, marine, & casualty insurance
Sub-IndustryProperty & Casualty Insurance


Debt-to-Equity Ratio0.24
Current Ratio0.39
Quick Ratio0.39


Trailing P/E Ratio18.74
Forward P/E Ratio22.03
P/E GrowthN/A

Sales & Book Value

Annual Sales$866.15 million
Price / Sales2.32
Cash Flow$2.6448 per share
Price / Cash14.16
Book Value$29.86 per share
Price / Book1.25


EPS (Most Recent Fiscal Year)$2.02
Net Income$107.26 million
Net Margins9.20%
Return on Equity5.64%
Return on Assets1.99%


Outstanding Shares53,590,000
Market Cap$1,950.82

The Truth About Cryptocurrencies

ProAssurance (NYSE:PRA) Frequently Asked Questions

What is ProAssurance's stock symbol?

ProAssurance trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRA."

How often does ProAssurance pay dividends? What is the dividend yield for ProAssurance?

ProAssurance declared a quarterly dividend on Wednesday, May 23rd. Shareholders of record on Friday, June 22nd will be paid a dividend of $0.31 per share on Tuesday, July 10th. This represents a $1.24 dividend on an annualized basis and a yield of 3.31%. The ex-dividend date is Thursday, June 21st. View ProAssurance's Dividend History.

How were ProAssurance's earnings last quarter?

ProAssurance Co. (NYSE:PRA) announced its quarterly earnings results on Thursday, May, 3rd. The insurance provider reported $0.40 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.44 by $0.04. The insurance provider earned $201.03 million during the quarter, compared to the consensus estimate of $219.42 million. ProAssurance had a net margin of 9.20% and a return on equity of 5.64%. The company's revenue for the quarter was down 9.9% compared to the same quarter last year. During the same period last year, the company earned $0.62 earnings per share. View ProAssurance's Earnings History.

When is ProAssurance's next earnings date?

ProAssurance is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for ProAssurance.

What price target have analysts set for PRA?

6 analysts have issued 1 year price targets for ProAssurance's shares. Their forecasts range from $50.00 to $54.00. On average, they expect ProAssurance's stock price to reach $52.00 in the next twelve months. This suggests a possible upside of 38.9% from the stock's current price. View Analyst Ratings for ProAssurance.

What is the consensus analysts' recommendation for ProAssurance?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ProAssurance in the last year. There are currently 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

What are Wall Street analysts saying about ProAssurance stock?

Here are some recent quotes from research analysts about ProAssurance stock:
  • 1. According to Zacks Investment Research, "ProAssurance’s shares have lost significantly when compared to its industry’s growth in the past year. Also, the company has witnessed its 2018 and 2019 earnings move downward over the past 90 days. Volatility in premium retention in the company’s physician business has impacted its margins adversely too. While growing expenses also persistently burden the company’s bottom line, declining investment income has been affecting its revenues. However, its core business has been witnessing substantial improvement over the past few quarters. It has significantly achieved inorganic growth via successful acquisitions and integration of companies. Its top line has also remained consistently strong on the back of a solid premium income." (7/15/2018)
  • 2. Boenning Scattergood analysts commented, "We anticipate some weakness in the shares today. The company is one of the more conservative insurers in the sector and has a long track record of building shareholder value (book value plus cumulative dividends), averaging 13% growth per year for the last 25 years. However, the stock is currently trading over 1.7x book versus the company’s long-term average of 1.4x. We also expect earnings to decline modestly over the next couple of years, largely the result of less favorable (albeit still very strong) prior year reserve development. As such, we believe investors should wait for a better opportunity to get into the stock and maintain our Neutral rating." (2/22/2018)

Are investors shorting ProAssurance?

ProAssurance saw a increase in short interest in the month of June. As of June 29th, there was short interest totalling 1,680,757 shares, an increase of 70.1% from the June 15th total of 987,882 shares. Based on an average daily volume of 1,010,168 shares, the days-to-cover ratio is presently 1.7 days. Approximately 3.2% of the shares of the stock are sold short. View ProAssurance's Current Options Chain.

Who are some of ProAssurance's key competitors?

Who are ProAssurance's key executives?

ProAssurance's management team includes the folowing people:
  • Mr. William Stancil Starnes Esq., J.D., Chairman, Pres & CEO (Age 69)
  • Mr. Edward Lewis Rand Jr., CPA, Exec. VP, COO, CFO & Chief Accounting Officer (Age 51)
  • Mr. Jeffrey Patton Lisenby, Exec. VP, Gen. Counsel, Corp. Sec. & Head of the Corp. Legal Dept (Age 49)
  • Mr. Howard Harley Friedman ACAS, Chief Underwriting Officer, Chief Actuary & Pres of Healthcare Professional Liability Group (Age 59)
  • Mr. Michael Leonard Boguski CPCU, Pres of Eastern Insurance (Age 55)

Has ProAssurance been receiving favorable news coverage?

Press coverage about PRA stock has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. ProAssurance earned a media sentiment score of 0.06 on Accern's scale. They also gave news articles about the insurance provider an impact score of 45.47 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are ProAssurance's major shareholders?

ProAssurance's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Bank of Montreal Can (0.61%), State of Alaska Department of Revenue (0.03%) and Xact Kapitalforvaltning AB (0.02%). Company insiders that own ProAssurance stock include Edward Lewis Rand Jr, Howard H Friedman, Jeffrey Patton Lisenby, Magnus James Gorrie, Neil Frank B O and William Stancil Starnes. View Institutional Ownership Trends for ProAssurance.

Which institutional investors are selling ProAssurance stock?

PRA stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View Insider Buying and Selling for ProAssurance.

Which institutional investors are buying ProAssurance stock?

PRA stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can and Xact Kapitalforvaltning AB. Company insiders that have bought ProAssurance stock in the last two years include Howard H Friedman, Magnus James Gorrie and Neil Frank B O. View Insider Buying and Selling for ProAssurance.

How do I buy shares of ProAssurance?

Shares of PRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ProAssurance's stock price today?

One share of PRA stock can currently be purchased for approximately $37.45.

How big of a company is ProAssurance?

ProAssurance has a market capitalization of $1.95 billion and generates $866.15 million in revenue each year. The insurance provider earns $107.26 million in net income (profit) each year or $2.02 on an earnings per share basis. ProAssurance employs 994 workers across the globe.

How can I contact ProAssurance?

ProAssurance's mailing address is 100 Brookwood Place, Birmingham AL, 35209. The insurance provider can be reached via phone at 205-877-4400 or via email at [email protected]

MarketBeat Community Rating for ProAssurance (NYSE PRA)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  174 (Vote Outperform)
Underperform Votes:  216 (Vote Underperform)
Total Votes:  390
MarketBeat's community ratings are surveys of what our community members think about ProAssurance and other stocks. Vote "Outperform" if you believe PRA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.